Circ Cardiovasc Qual Outcomes -- Table of Contents (1 [2])

Volume 1, Issue 2; November, 2008

Editorials
Original Articles
Cardiovascular Perspectives
Primer on Statistical Interpretation or Methods
Author Index

To see an article, click its "Full Text" or "PDF" link. To review many abstracts, check the boxes to the left of the titles you want, and click the "Get All Checked Abstract(s)" button. To see one abstract at a time, click its "Abstract" link.

button_lock_image article is free immediately upon publication

	Editorials
	Pharmacotherapy for Pediatric Cardiovascular Diseases: The Role of Off-Label Drug Use in the 21st Century John C. Ring Circ Cardiovasc Qual Outcomes. 2008;1:69-71, doi:10.1161/CIRCOUTCOMES.108.830935 Extract \| Full Text \| PDF
	Anticoagulation Control in Atrial Fibrillation: Optimizing Risks and Benefits Alawi A. Alsheikh-Ali and N.A. Mark Estes, III Circ Cardiovasc Qual Outcomes. 2008;1:72-73, doi:10.1161/CIRCOUTCOMES.108.827329 Extract \| Full Text \| PDF
	Original Articles
	Off-Label Use of Cardiovascular Medications in Children Hospitalized With Congenital and Acquired Heart Disease Sara K. Pasquali, Matthew Hall, Anthony D. Slonim, Kathy J. Jenkins, Bradley S. Marino, Meryl S. Cohen, and Samir S. Shah Circ Cardiovasc Qual Outcomes. 2008;1:74-83; published online before print November 5 2008, doi:10.1161/CIRCOUTCOMES.108.787176 Abstract \| Full Text \| PDF
	Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation: A Systematic Review Yi Wan, Carl Heneghan, Rafael Perera, Nia Roberts, Jennifer Hollowell, Paul Glasziou, Clare Bankhead, and Yongyong Xu Circ Cardiovasc Qual Outcomes. 2008;1:84-91; published online before print November 5 2008, doi:10.1161/CIRCOUTCOMES.108.796185 Abstract \| Full Text \| PDF \| Clinical Perspective
	C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study Peter W.F. Wilson, Michael Pencina, Paul Jacques, Jacob Selhub, Ralph D'Agostino, Sr, and Christopher J. O'Donnell Circ Cardiovasc Qual Outcomes. 2008;1:92-97; published online before print November 9 2008, doi:10.1161/CIRCOUTCOMES.108.831198 Abstract \| Full Text \| PDF \| Clinical Perspective
	A Novel Family-Based Intervention Trial to Improve Heart Health: FIT Heart: Results of a Randomized Controlled Trial Lori Mosca, Heidi Mochari, Ming Liao, Allison H. Christian, Dana J. Edelman, Brooke Aggarwal, and Mehmet C. Oz Circ Cardiovasc Qual Outcomes. 2008;1:98-106; published online before print November 12 2008, doi:10.1161/CIRCOUTCOMES.108.825786 Abstract \| Full Text \| PDF \| Clinical Perspective
	Effects of Ranolazine on Disease-Specific Health Status and Quality of Life Among Patients With Acute Coronary Syndromes: Results from the MERLIN-TIMI 36 Randomized Trial Suzanne V. Arnold, David A. Morrow, Kaijun Wang, Yang Lei, Elizabeth M. Mahoney, Benjamin M. Scirica, Eugene Braunwald, David J. Cohen on behalf of the MERLIN-TIMI 36 Investigators Circ Cardiovasc Qual Outcomes. 2008;1:107-115; published online before print November 5 2008, doi:10.1161/CIRCOUTCOMES.108.798009 Abstract \| Full Text \| PDF \| Clinical Perspective
	Coronary Revascularization at Specialty Cardiac Hospitals and Peer General Hospitals in Black Medicare Beneficiaries Brahmajee K. Nallamothu, Xin Lu, Mary S. Vaughan-Sarrazin, and Peter Cram Circ Cardiovasc Qual Outcomes. 2008;1:116-122; published online before print November 5 2008, doi:10.1161/CIRCOUTCOMES.108.800086 Abstract \| Full Text \| PDF
	Sex and Gender Discrepancies in Health-Related Quality of Life Outcomes Among Patients With Established Coronary Artery Disease Colleen M. Norris, John A. Spertus, Louise Jensen, Jeff Johnson, Kathleen M. Hegadoren, William A. Ghali for the APPROACH Investigators Circ Cardiovasc Qual Outcomes. 2008;1:123-130; published online before print November 5 2008, doi:10.1161/CIRCOUTCOMES.108.793448 Abstract \| Full Text \| PDF
	Cardiovascular Perspectives
	Prevention of Future Cardiovascular Disease in High-Risk Pediatric Patients: A Role for Lipid Lowering Therapy? Sara K. Pasquali and Jennifer S. Li Circ Cardiovasc Qual Outcomes. 2008;1:131-133, doi:10.1161/CIRCOUTCOMES.108.819235 Extract \| Full Text \| PDF
	Reexamining the Emperor’s New Clothes: Ambiguities in Current Cardiac Screening Recommendations for Youth With Attention Deficit Hyperactivity Disorder Laurel K. Leslie, Mark E. Alexander, Thomas A. Trikalinos, Joshua T. Cohen, Susan K. Parsons, and Jane W. Newburger Circ Cardiovasc Qual Outcomes. 2008;1:134-137, doi:10.1161/CIRCOUTCOMES.108.825232 Extract \| Full Text \| PDF
	Primer on Statistical Interpretation or Methods
	The Cardiovascular Research Network: A New Paradigm for Cardiovascular Quality and Outcomes Research Alan S. Go, David J. Magid, Barbara Wells, Sue Hee Sung, Andrea E. Cassidy-Bushrow, Robert T. Greenlee, Robert D. Langer, Tracy A. Lieu, Karen L. Margolis, Frederick A. Masoudi, Catherine J. McNeal, Glen H. Murata, Katherine M. Newton, Rachel Novotny, Kristi Reynolds, Douglas W. Roblin, David H. Smith, Suma Vupputuri, Robert E. White, Jean Olson, John S. Rumsfeld, and Jerry H. Gurwitz Circ Cardiovasc Qual Outcomes. 2008;1:138-147, doi:10.1161/CIRCOUTCOMES.108.801654 Abstract \| Full Text \| PDF
	Author Index
	Volume 1, September–November 2008 Circ Cardiovasc Qual Outcomes. 2008;1:148-149, doi:10.1161/01.CIRCOUTCOMES.0000341765.54439.02 Extract \| Full Text \| PDF

Spotlight

TOC Spotlight File

Volume 1, Issue 2; November, 2008

Editorials

Pharmacotherapy for Pediatric Cardiovascular Diseases: The Role of Off-Label Drug Use in the 21st Century

Anticoagulation Control in Atrial Fibrillation: Optimizing Risks and Benefits

Original Articles

Off-Label Use of Cardiovascular Medications in Children Hospitalized With Congenital and Acquired Heart Disease

Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation: A Systematic Review

C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study

A Novel Family-Based Intervention Trial to Improve Heart Health: FIT Heart: Results of a Randomized Controlled Trial

Effects of Ranolazine on Disease-Specific Health Status and Quality of Life Among Patients With Acute Coronary Syndromes: Results from the MERLIN-TIMI 36 Randomized Trial

Coronary Revascularization at Specialty Cardiac Hospitals and Peer General Hospitals in Black Medicare Beneficiaries

Sex and Gender Discrepancies in Health-Related Quality of Life Outcomes Among Patients With Established Coronary Artery Disease

Cardiovascular Perspectives

Prevention of Future Cardiovascular Disease in High-Risk Pediatric Patients: A Role for Lipid Lowering Therapy?

Reexamining the Emperor’s New Clothes: Ambiguities in Current Cardiac Screening Recommendations for Youth With Attention Deficit Hyperactivity Disorder

Primer on Statistical Interpretation or Methods

The Cardiovascular Research Network: A New Paradigm for Cardiovascular Quality and Outcomes Research

Author Index

Volume 1, September–November 2008

Spotlight